Drug intelligence / Profile preview

MS-Ten

Development stage
Unknown
Lead developer
Atlantic Laboratories
Modality
Small Molecules
Administration
Oral
01

Overview

MS-Ten is a brand name for an immediate-release oral formulation of morphine sulfate, a potent opioid analgesic derived from the opium poppy. It functions as a full agonist at the mu-opioid receptors (MOR) within the central nervous system, where it inhibits the release of nociceptive neurotransmitters and activates descending inhibitory pathways to provide profound analgesia. Morphine also interacts with kappa (KOR) and delta (DOR) opioid receptors, though with lower affinity. MS-Ten is specifically provided as a 10 mg tablet and is indicated for the management of acute and chronic pain that is severe enough to require an opioid and for which alternative analgesics are inadequate. Developed and manufactured by companies such as Atlantic Laboratories, it is a standard treatment in palliative care and for severe post-operative or trauma-related pain.

Brand names
MS-Ten
Other names
morphine sulfatemorphine
02

Targets

MOR (Mu opioid receptor)

Beyond the preview

Go deeper on MS-Ten.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MS-Ten.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call